相似文献
1
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity.
J Psychopharmacol. 2012 Jan;26(1):92-103. doi: 10.1177/0269881111400652. Epub 2011 Mar 29.
2
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS.
Curr Neuropharmacol. 2011 Mar;9(1):205-8. doi: 10.2174/157015911795017416.
3
Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands.
Genes Brain Behav. 2009 Jul;8(5):519-30. doi: 10.1111/j.1601-183X.2009.00498.x. Epub 2009 Jun 3.
4
Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.
Ann N Y Acad Sci. 2006 Aug;1074:514-36. doi: 10.1196/annals.1369.052.
5
Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption.
Ann N Y Acad Sci. 2008 Oct;1139:426-33. doi: 10.1196/annals.1432.035.
6
What we know and do not know about the cannabinoid receptor 2 (CB2).
Semin Immunol. 2014 Oct;26(5):369-79. doi: 10.1016/j.smim.2014.04.002. Epub 2014 May 28.
7
Differential expression and functional role of cannabinoid genes in alcohol users.
Drug Alcohol Depend. 2013 Dec 1;133(2):789-93. doi: 10.1016/j.drugalcdep.2013.08.023. Epub 2013 Sep 5.
8
Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain.
Neuropsychobiology. 2006;54(4):231-46. doi: 10.1159/000100778. Epub 2007 Mar 15.
9
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Cell Immunol. 2014 Jan;287(1):1-17. doi: 10.1016/j.cellimm.2013.11.002. Epub 2013 Nov 14.
10
Cannabinoid receptors in microglia of the central nervous system: immune functional relevance.
J Leukoc Biol. 2005 Dec;78(6):1192-7. doi: 10.1189/jlb.0405216. Epub 2005 Oct 4.
引用本文的文献
1
Role of the Endocannabinoid System in Fibromyalgia.
Curr Issues Mol Biol. 2025 Mar 27;47(4):230. doi: 10.3390/cimb47040230.
2
The effect of a synthetic cannabinoid agonist (nabilone) on unimodal tactile illusion correlates with a psychometric scores in healthy volunteers.
Sci Rep. 2025 May 27;15(1):18469. doi: 10.1038/s41598-025-02280-9.
3
Coadministration antagonist dopamine receptor D4 with CB2 receptor agonist decreases binge-like intake of palatable food in mice.
Front Behav Neurosci. 2025 Apr 29;19:1572374. doi: 10.3389/fnbeh.2025.1572374. eCollection 2025.
4
Efficacy and Safety of Cannabinoids for Autism Spectrum Disorder: An Updated Systematic Review.
Cureus. 2025 Mar 17;17(3):e80725. doi: 10.7759/cureus.80725. eCollection 2025 Mar.
5
The effect of cannabinoid type Ⅱ receptor on the excitability of substantia nigra dopaminergic neurons.
Front Pharmacol. 2025 Feb 14;16:1522210. doi: 10.3389/fphar.2025.1522210. eCollection 2025.
6
Modeling the Effect of Cannabinoid Exposure During Human Neurodevelopment Using Bidimensional and Tridimensional Cultures.
Cells. 2025 Jan 7;14(2):70. doi: 10.3390/cells14020070.
7
The Potential of JWH-133 to Inhibit the TLR4/NF-κB Signaling Pathway in Uterine Ischemia-Reperfusion Injury.
Life (Basel). 2024 Sep 24;14(10):1214. doi: 10.3390/life14101214.
8
Alcohol induced behavioral and immune perturbations are attenuated by activation of CB2 cannabinoid receptors.
Adv Drug Alcohol Res. 2023 Dec 19;3:11602. doi: 10.3389/adar.2023.11602. eCollection 2023.
9
Cannabinoid CB2 receptors and hypersensitivity to methamphetamine: Vulnerability to schizophrenia.
Prog Neuropsychopharmacol Biol Psychiatry. 2024 Mar 2;130:110924. doi: 10.1016/j.pnpbp.2023.110924. Epub 2023 Dec 20.
10
Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review.
Pharmacol Rep. 2023 Dec;75(6):1410-1444. doi: 10.1007/s43440-023-00544-7. Epub 2023 Oct 31.
本文引用的文献
1
Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders.
Pharmaceuticals (Basel). 2010 Aug 10;3(8):2517-2553. doi: 10.3390/ph3082517.
2
Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice.
Neuropsychopharmacology. 2011 Jun;36(7):1489-504. doi: 10.1038/npp.2011.34. Epub 2011 Mar 23.
3
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine.
Neurobiol Aging. 2012 Feb;33(2):421.e1-16. doi: 10.1016/j.neurobiolaging.2010.09.012. Epub 2010 Oct 27.
4
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice.
J Psychopharmacol. 2011 Jan;25(1):111-20. doi: 10.1177/0269881110379507. Epub 2010 Sep 13.
5
Distribution of CB2 cannabinoid receptor in adult rat retina.
Synapse. 2011 May;65(5):388-92. doi: 10.1002/syn.20856. Epub 2010 Oct 8.
6
Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors.
Br J Pharmacol. 2010 Aug;160(7):1773-84. doi: 10.1111/j.1476-5381.2010.00819.x.
7
Endocannabinoid system, pharmacogenomics and response to therapy.
Pharmacogenomics. 2010 Jul;11(7):907-10. doi: 10.2217/pgs.10.91.
8
CB2: a cannabinoid receptor with an identity crisis.
Br J Pharmacol. 2010 Jun;160(3):467-79. doi: 10.1111/j.1476-5381.2010.00729.x.
9
Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis.
J Psychopharmacol. 2011 Jan;25(1):97-104. doi: 10.1177/0269881110367732. Epub 2010 May 20.
10
Genome-wide approaches to schizophrenia.
Brain Res Bull. 2010 Sep 30;83(3-4):93-102. doi: 10.1016/j.brainresbull.2010.04.009. Epub 2010 Apr 28.
Zotero 插件